Differences in oxidative stress dependence between gastric adenocarcinoma subtypes

doi:10.3748/wjg.v12.i7.1005

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 7

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3471)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

340

HTML

2526

Figures (1-1)

280

Tables (1-4)

325

Sum=3471

Feb 21, 2006 (publication date) through Mar 7, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Gastric Cancer

World J Gastroenterol. Feb 21, 2006; 12(7): 1005-1012
Published online Feb 21, 2006. doi: 10.3748/wjg.v12.i7.1005

Table 1 Correlation of staining with clinicopathologic data

Clinicopathologic features^a	iNOS^bNo. of casesTotal positive (%)	NTYR^bNo. of casesTotal positive (%)	8OH-dG^bNo. of casesTotal positive (%)
Infiltrative cancer subtypes	85 35 (41)	65 40 (62)	82 41 (50)
TC	54 29¹ (54¹)	43 312 ( 72²)	54 28 (52)
DC	17 3¹ ( 18¹)	12 6 (50)	14 7 (50)
PolyC	14 3¹ (21¹)	10 3² ( 30²)	14 6 (43)
Intraepithelial cancer
Periinfiltrative cancer	5 3 (60)	6 4 (67)	6 4 (67)
Without infiltrative cancer	7 1 (14)	7 6 (86)	10 5 (50)
Topography of infiltrative cancer
Cardia	10 4 (40)	7 3 (43)	11 5 (45)
Gastric stump	12 6 (50)	9 5 (56)	8 3 (38)
Antrum with angulus+pylorus	45 18 (40)	35 22 (63)	41 22 (54)
Body	14 7 (50)	11 9 (82)	15 11 (73)
Peritumorous mucosa
Adjacent: N + no IM G	15 5 (33)	23 9 (39)	30 10 (33)
Adjacent: atrophy IM	23 14 (61)	21 10 (48)	26 18 (69)
At distance: N + no IM G	3 1 (33)	6 1 (17)	5 2 (40)
At distance: atrophy IM	7 4 (57)	7 5 (71)	13 9 (69)
Adjacent+distant: N + no IM G`	18 6 (33)	29 10 (34)	35 12³ (34³)
Adjacent+distant: atrophy IM	30 18 (60)	28 15 (54)	39 27 (69)
Precancerous lesions
Low grade dysplasia	13 9 (69)	14 11 (79)	17 14³ (82³)
Atrophy IM without cancer	10 8 (80)	7 7 (100)	11 6 (55)
Atrophy IM with + without cancer	40 26 (65)	35 22 (63)	50 33³ (66³)
H pylori infection
Negative	68 27 (40)	54 35 (65)	77 41 (53)
Positive	18 7 (39)	13 7 (54)	16 9 (56)
Sex
Male	60 28 (47)	50 32 (64)	66 36 (55)
Female	30 8 (27)	29 20 (69)	35 18 (51)

(a) TC: Intestinal or tubular carcinoma; DC: Diffuse carcinoma; PolyC: Mixed polymorphous carcinoma; N: Normal; IM: Intestinal metaplasia; G: Gastritis. (b) iNOS: Inducible nitric oxide synthase; NTYR: Nitrotyrosine; 8OH-dG: 8-hydroxy-2’-deoxyguanosine.

¹TC vs DC P = 0.008; TC vs PolyC, P = 0.04; TC vs DC+PolyC, P = 0.04;

²TC vs PolyC. P = 0.03;

³non-metaplastic mucosa atrophic metaplastic mucosa low-grade dysplasia, P = 0.005.

Table 2 Correlation of staining with pTNM pathological classification^a

Pathological classification^b	iNOS^cNo. of casesTotal positive (%)	NTYR^cNo. of casesTotal positive (%)	8OH-dG^cNo. of casesTotal positive (%)
pTis	7 1 (14)	7 6 (86)	10 5 (50)
pT1	18 7 (39)	16 12 (75)	16 10 (63)
TC	13 7 (54)	12 9 (75)	12 8 (67)
DC	3 0 (0)	2 2 (100)	2 2 (100)
PolyC	2 0 (0)	2 1 (50)	2 0 (0)
pT2	7 3 (43)	8 6 (75)	8 4 (50)
TC	5 2 (40)	6 5 (83)	6 3 (50)
DC	0 0 (0)	0 0 (0)	0 0 (0)
PolyC	2 1 (50)	2 1 (50)	2 1 (50)
pT3/T4	22 9 (41)	15 8 (53)	21 10 (48)
TC	12 7 (58)	8 6 (75)	12 6 (50)
DC	5 1 (20)	3 1 (33)	4 2 (50)
PolyC	5 1 (20)	4 1 (25)	5 2 (40)
pN0	20 10 (50)	20 14 (70)	20 11 (55)
TC	16 8 (50)	16 13 (81)	16 10 (63)
DC	1 1 (100)	1 0 (0)	1 1 (100)
PolyC	3 1 (33)	3 1 (33)	3 0 (0)
pN+	24 8 (33)	17 9 (53)	22 11 (50)
TC	10 6 (60)	7 4 (57)	10 4 (40)
DC	7 0 (0)	5 3 (60)	5 3 (60)
PolyC	7 2 (29)	5 2 (40)	7 4 (57)
pM0	38 14 (37)	3 21 (64)	36 20 (56)
TC	25 12 (48)	2 17 (77)	25 15 (60)
DC	6 1 (17)	4 2 (50)	4 4 (100)
PolyC	7 1 (14)	7 2 (29)	7 1 (14)
pM1	16 9 (56)	12 8 (67)	16 8 (50)
TC	9 7 (78)	8 6 (75)	9 5 (56)
DC	4 0 (0)	3 2 (67)	4 1 (25)
PolyC	3 2 (67)	1 0 (0)	3 2 (67)

(a) Determination according to the newly revised classification of the AJCC and UICC. (b) TC: Intestinal or tubular carcinoma; DC: Diffuse carcinoma; PolyC: Mixed polymorphous carcinoma. (c) iNOS: Inducible nitric oxide synthase; NTYR: Nitrotyrosine; 8OH-dG: 8-hydroxy-2’-deoxyguanosine

Table 3 Correlation of staining with stage grouping^a

Stages^b	iNOS^cNo. of casesTotal positive(%)	NTYR^cNo. of casesTotal positive (%)	8OH-dG^cNo. of casesTotal positive (%)
Stage 0	7 1 (14)	7 6 (86)	10 5 (50)
Stage I	22 9 (41)	21 15 (71)	21 12 (57)
TC	16 8 (50)	16 12 (75)	16 10 (63)
DC	3 0 (0)	2 2 (100)	2 2 (100)
PolyC	3 1 (33)	3 1 (33)	3 0 (0)
Stage II+III	13 5 (38)	10 4 (40)	12 5 (42)
TC	8 4 (50)	5 4 (80)	7 3 (43)
DC	2 1 (50)	2 0 (0)	2 2 (100)
PolyC	3 0 (0)	3 0 (0)	3 0 (0)
Stage IV	19 9 (47)	14 10 (71)	18 10 (56)
TC	9 7 (78)	8 6 (75)	9 5 (56)
DC	5 0 (0)	3 2 (67)	4 1 (25)
PolyC	5 2 (40)	3 2 (67)	5 4 (80)
All stages (early cancer excluded)	36 16 (44)	29 17 (59)	35 17 (49)
TC	20 12 (60)	17 13 (76)	20 10 (50)
DC	7 1 (14)	5 2 (40)	6 3 (50)
DC+PolyC	16 4 (25)	12 4 (33)	15 7 (47)
Early cancer (pTis + pT1)	25 8 (32)	23 18 (78)	26 15 (58)
TC	20 8 (40)	19 15 (79)	22 13 (59)
DC	3 0 (0)	2 2 (100)	2 2 (100)
DC+PolyC	5 0 (0)	4 3 (75)	4 2 (50)

Table 4 Co-occurrence of immunostaining for iNOS, NTYR and 8-OH-dG^a

Markers	No. of samples (%)
Markers	TC^bn = 40	DC^bn = 12	PolyC^bn = 10
All negative	5 (12)	2 (16)	5 (50)
One positive
iNOS	2 (5)	1 (8)	1 (10)
NTYR	4 (10)	2 (17)	1 (10)
8-OHdG	2 (5)	2 (17)	1 (10)
Two positive
iNOS + NTYR	8 (20)	1 (8)	0 (0)
NTYR + 8-OHdG	8 (20)	3 (25)	2 (20)
iNOS + 8-OHdG	1 (2.5)	1 (8)	0 (0)
All positive
iNOS + NTYR + 8-OHdG	10 (25)	0 (0)	0 (0)

(a) iNOS: Inducible nitric oxide synthase; NTYR: Nitrotyrosine; 8OH-dG: 8-hydroxy-2’-deoxyguanosine. (b) TC: Intestinal or tubular carcinoma; DC: Diffuse carcinoma; PolyC: Mixed polymorphous carcinoma.

Citation: Bancel B, Estève J, Souquet JC, Toyokuni S, Ohshima H, Pignatelli B. Differences in oxidative stress dependence between gastric adenocarcinoma subtypes. World J Gastroenterol 2006; 12(7): 1005-1012
URL: https://www.wjgnet.com/1007-9327/full/v12/i7/1005.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i7.1005